ArticleThoracic cancer2018

Successful treatment with nivolumab for lung cancer with low expression of PD-L1 and prominent tumor-infiltrating B cells and immunoglobulin G.

Takayuki Suyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.